Is Bristol Myers Squibb Stock a Buy?

Is Bristol Myers Squibb Stock a Buy?

Bristol Myers Squibb (NYSE: BMY) underperformed the S&P 500 index in each of the last four years, and it's on the way to extending the streak to five. Or is Bristol Myers Squibb a stock to buy right now? If BMS can deliver strong revenue and earnings growth, the big pharma stock could also generate market-beating returns.